NORTHFIELD LABORATORIES INC /DE/
DFAN14A, 2000-08-02
BIOLOGICAL PRODUCTS, (NO DIAGNOSTIC SUBSTANCES)
Previous: ANCOR COMMUNICATIONS INC /MN/, 15-12G, 2000-08-02
Next: ITT EDUCATIONAL SERVICES INC, 4, 2000-08-02



                            SCHEDULE 14A INFORMATION
                Proxy Statement Pursuant to Section 14(a) of the
                        Securities Exchange Act of 1934
                                (Amendment No. )

Filed by the Registrant  [  ]

Filed by a Party other than the Registrant  [ X]

Check the appropriate box:

[  ]  Preliminary Proxy Statement

[  ]  Confidential, for Use of the Commission Only (as permitted by Rule
      14a-6(e)(2))

[  ]  Definitive Proxy Statement

[  ]  Definitive Additional Materials

[X ]  Soliciting Material Pursuant to Sections 240.14a-11(c) or Section
      240.14a-12

                              NORTHFIELD LABORATORIES, INC.
--------------------------------------------------------------------------------
                (Name of Registrant as Specified In Its Charter)


                           MANAGEMENT INSIGHTS, INC.
--------------------------------------------------------------------------------
    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

Payment of Filing Fee (Check the appropriate box):

[ X]  No fee required

[  ]  Fee computed on table below per Exchange Act Rules 14a-6(i)(4) and 0-11

   1) Title of each class of securities to which transaction applies:

   2) Aggregate number of securities to which transaction applies:

   3)  Per unit price or other underlying value of transaction computed pursuant
       to Exchange Act Rule 0-11 (set forth the amount on which the filing fee
       is calculated and state how it was determined):

   4) Proposed maximum aggregate value of transaction:

   5) Total fee paid:

[  ]  Fee paid previously with preliminary materials

[     ] Check box if any part of the fee is offset as provided by Exchange Act
      Rule 0-11(a)(2) and identify the filing for which the offsetting fee was
      paid previously. Identify the previous filing by registration statement
      number, or the Form or Schedule and the date of its filing.

   1) Amount Previously Paid:

   2) Form, Schedule or Registration Statement No.:

   3) Filing Party:

   4) Date Filed:

<PAGE>



FOR IMMEDIATE RELEASE
---------------------

Contact:
Michael Eden
Management Insights, Inc.
14755 Preston Road   Suite 525
Dallas, TX 75240
(972) 755-2064
[email protected]
----------------------------

C. Robert Coates and Management Insights, Inc. Provide Status Update to
Shareholders of Northfield Labs

Dallas/August 2, 2000/PRNewswire/ -- -- C. Robert Coates and Management
Insights, Inc. (MII) today confirmed that a meeting between MII and Northfield
Labs (NASDAQ: NFLD) has occurred. This meeting followed up the letter MII sent
to Northfield shareholders on June 19, 2000.

"I met with Mr. DeWoskin, Northfield Labs' CEO, and Mr. Gould, Northfield Labs'
President, on Monday, July 24, 2000", said Mr. Coates. "In response to Mr.
DeWoskin's request for clarification of the shareholder letter, I made the
following points:

     o        The consensus feedback from shareholders responding to our letter
              strongly supports our contention that the company's "Wall of
              Silence" approach to shareholder and media relations has greatly
              increased the perceived level of risk in the company's ability to
              achieve its milestones.

     o        Based on current market conditions and market capitalization
              comparisons with same stage competitors such as Biopure
              Corporation and Alliance Pharmaceutical, Northfield Labs shares
              remain greatly undervalued.

     o        By communicating the company's notable achievements, product
              status, and the known role the company's products have already
              played in saving lives, Northfield Labs can achieve a market
              capitalization comparable to its competitors.

     o        By maximizing shareholder value now, it will be possible for the
              company to raise additional funds in the capital markets. This
              will ensure the company's ability to implement marketing and
              manufacturing activities in the future."

Mr. Coates also noted that, by mutual consent, "no information was discussed in
the meeting that is not available to other shareholders of Northfield Labs. We
will continue to evaluate our options moving forward."

                                       ***
About Management Insights, Inc.
-------------------------------
Management Insights, Inc. (MII) is a diversified management consulting, venture
capital, and investment firm. Its customers include a number of Fortune 500
companies. Among its public investments are large equity stakes in Inprise
Corporation, Evolving Systems, and Northfield Labs. Through its ProxyCapital
Partners, Inc. subsidiary, MII serves as fund manager for ProxyCapital LP, a
value-oriented hedge fund.





© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission